Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendall J Blumer

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|December 17, 2021
Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanomaMichael D Onken, Sarah E Noda, Kevin M Kaltenbronn, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 13, 2010
Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholineHans H Dietrich, Dana R Abendschein, Sung Ho Moon, et al.
Science Signaling|September 6, 2018
Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cellsMichael D Onken, Carol M Makepeace, Kevin M Kaltenbronn, et al.
Molecular & Cellular Proteomics : MCP|September 20, 2023
Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic AnalysesMichael D Onken, Petra Erdmann-Gilmore, Qiang Zhang, et al.
Nature Medicine|November 11, 2003
Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressureK Mary Tang, Guang-rong Wang, Ping Lu, et al.
The Journal of Clinical Investigation|November 5, 2003
Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiencyGilles Faury, Mylène Pezet, Russell H Knutsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Chloroquine Sensitizes <i>GNAQ/11</i>-mutated Melanoma to MEK1/2 InhibitionAmanda Truong, Jae Hyuk Yoo, Michael T Scherzer, et al.
Journal of Molecular and Cellular Cardiology|February 5, 2011
RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signalingKhalid Chakir, Weizhong Zhu, Sharon Tsang, et al.
The Journal of Clinical Investigation|February 18, 2003
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient miceScott P Heximer, Russell H Knutsen, Xiaoguang Sun, et al.
The Journal of Clinical Investigation|April 17, 2003
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient miceScott P Heximer, Russell H Knutsen, Xiaoguang Sun, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|December 17, 2021
Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanomaMichael D Onken, Sarah E Noda, Kevin M Kaltenbronn, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 13, 2010
Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholineHans H Dietrich, Dana R Abendschein, Sung Ho Moon, et al.
Science Signaling|September 6, 2018
Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cellsMichael D Onken, Carol M Makepeace, Kevin M Kaltenbronn, et al.
Molecular & Cellular Proteomics : MCP|September 20, 2023
Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic AnalysesMichael D Onken, Petra Erdmann-Gilmore, Qiang Zhang, et al.
Nature Medicine|November 11, 2003
Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressureK Mary Tang, Guang-rong Wang, Ping Lu, et al.
The Journal of Clinical Investigation|November 5, 2003
Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiencyGilles Faury, Mylène Pezet, Russell H Knutsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Chloroquine Sensitizes <i>GNAQ/11</i>-mutated Melanoma to MEK1/2 InhibitionAmanda Truong, Jae Hyuk Yoo, Michael T Scherzer, et al.
Journal of Molecular and Cellular Cardiology|February 5, 2011
RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signalingKhalid Chakir, Weizhong Zhu, Sharon Tsang, et al.
The Journal of Clinical Investigation|February 18, 2003
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient miceScott P Heximer, Russell H Knutsen, Xiaoguang Sun, et al.
The Journal of Clinical Investigation|April 17, 2003
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient miceScott P Heximer, Russell H Knutsen, Xiaoguang Sun, et al.
Pageof 7